Antibiotic-resistant bloodstream infections fall for first time in five years A report by the UK Health Security Agency has revealed that the overall proportion of infections resistant to one or more antibiotics in England has risen since 2016.…
Study results show blood test could predict treatment response in people with prostate cancer Researchers looked at circulating tumour cells in blood samples to identify changes in response to chemotherapy treatment.…
Selective serotonin reuptake inhibitors reduce mortality in patients with COVID-19, study suggests Data from 3,401 patients with COVID-19 who took selective serotonin reuptake inhibitors showed that the relative risk of mortality was reduced by 28% in those treated with fluoxetine.…
Majority of UK pharmacy schools are ‘decolonising’ their degree programmes Exclusive: Nearly 90% of institutions who responded to a freedom of information request said they were committed to 'decolonising' their pharmacy curriculum.…
Pale and stale: decolonising the pharmacy degree In this episode, we take a closer look at what can be done to make the MPharm curriculum and the wider healthcare sciences more inclusive.… Supported content
Combined HRT could reduce all-cause mortality by 9%, study results show The authors of the study concluded that the research "strengthens the emerging consensus" that, for most women, the benefits of hormone replacement therapy outweigh the harms.…
Chief and lead pharmacists for NHS genomic medicine service regions appointed Exclusive: Senior pharmacists have been appointed across the NHS Genomic Medicine Service Alliances.…
Oral antiviral may cut risk of COVID-19 hospitalisation by nearly 90%, manufacturer claims Results from an interim analysis suggest an investigational antiviral from Pfizer may reduce the risk of hospitalisation or death in COVID-19 patients.…
‘Game-changing’ COVID-19 antiviral drug gets approval in UK for at-risk patients Announcing the regulatory approval, Sajid Javid said the government is "working at pace" to deploy molnupiravir to patients in a national study "as soon as possible".…
Children discharged with pneumonia need only three days of antibiotic treatment, study results suggest Amoxicillin was found to be no less effective in children receiving the antibiotic for three days than it was in those who took it for seven days.…
